Quick Answer
ARROWHEAD PHARMACEUTICALS, INC. reported Total Revenue of $829.45 million for the year ending 2025.
- ARROWHEAD PHARMACEUTICALS, INC. showed an increase of +23,258.2% in Total Revenue from 2024 to 2025.
- This data is from ARROWHEAD PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on November 25, 2025.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $43.8 thousand | Q2 2014: $43.8 thousand | Q3 2014: $43.8 thousand | Q4 2014: $170.8 thousand | Q1 2015: $43.8 thousand | Q2 2015: $123.8 thousand | Q3 2015: $43.8 thousand | Q4 2015: $43.8 thousand | Q1 2016: $43.8 thousand | Q2 2016: $39.6 thousand | Q3 2016: $31.3 thousand | Q4 2016: $4.37 million | Q1 2017: $8.99 million | Q2 2017: $9.34 million | Q3 2017: $8.71 million | Q4 2017: $3.51 million | Q4 2017: $3.51 million | Q1 2018: $650.1 thousand | Q1 2018: $650.1 thousand | Q2 2018: $727.4 thousand | Q2 2018: $727.4 thousand | Q3 2018: $11.26 million | Q3 2018: $11.26 million | Q4 2018: $34.66 million | Q1 2019: $48.15 million | Q2 2019: $42.70 million | Q3 2019: $43.29 million | Q4 2019: $29.46 million | Q1 2020: $23.53 million | Q2 2020: $27.38 million | Q3 2020: $7.63 million | Q4 2020: $21.30 million | Q1 2021: $32.81 million | Q2 2021: $45.89 million | Q4 2021: $27.44 million | Q1 2022: $151.81 million | Q2 2022: $32.41 million | Q4 2022: $62.55 million | Q1 2023: $146.27 million | Q2 2023: $15.83 million | Q4 2023: $3.55 million | Q1 2024: $0.00 | Q2 2024: $0.00 | Q4 2024: $2.50 million | Q1 2025: $542.71 million | Q2 2025: $27.77 million | Q4 2025: $264.03 million.
- Over the full 17 years of available data (2011 to 2025), ARROWHEAD PHARMACEUTICALS, INC.'s Total Revenue has grown by 279,987.4%.
- Historical annual values: Fiscal year 2025: $829.45 million | Fiscal year 2024: $3.55 million | Fiscal year 2023: $240.74 million | Fiscal year 2022: $243.23 million | Fiscal year 2021: $138.29 million | Fiscal year 2020: $87.99 million | Fiscal year 2019: $168.80 million | Fiscal year 2018: $16.14 million | Fiscal year 2018: $16.14 million | Fiscal year 2017: $31.41 million | Fiscal year 2017: $31.41 million | Fiscal year 2016: $158.3 thousand | Fiscal year 2015: $382.0 thousand | Fiscal year 2014: $175.0 thousand | Fiscal year 2013: $290.3 thousand | Fiscal year 2012: $146.9 thousand | Fiscal year 2011: $296.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: